Gary Gillheeney | President and Chief Executive Officer |
Dave Francisco | Chief Financial Officer |
Ryan Zimmerman | BTIG |
Matt Miksic | Credit Suisse |
Ann Hite | SVB Leerink |
Steve Lichtman | Oppenheimer & Co. |
Please standby. Good afternoon, ladies and gentlemen and welcome to the Second Quarter 2021 Earnings Conference Call for Organogenesis Holdings, Inc. At this time all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company’s website for replay shortly.
Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company’s filings with the Securities and Exchange Commission, including Item 1A, risk factors on the company’s most recent annual and quarterly reports.